These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12355754)

  • 21. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
    J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
    Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
    Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 26. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune cells, pancreas development, regeneration and type 1 diabetes.
    Homo-Delarche F; Drexhage HA
    Trends Immunol; 2004 May; 25(5):222-9. PubMed ID: 15099561
    [No Abstract]   [Full Text] [Related]  

  • 28. [Molecular mechanisms of pancreatic beta-cell destruction in type 1 diabetes].
    Isotani H; Hanafusa T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():383-7. PubMed ID: 12238077
    [No Abstract]   [Full Text] [Related]  

  • 29. (Pro)insulin-specific regulatory T cells.
    Harrison LC; Solly NR; Martinez NR
    Novartis Found Symp; 2003; 252():132-41; discussion 141-5, 203-10. PubMed ID: 14609216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
    J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones.
    Haskins K
    J Autoimmun; 2004 Mar; 22(2):107-9. PubMed ID: 14987737
    [No Abstract]   [Full Text] [Related]  

  • 32. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between beta cell injury and antigen presentation in NOD mice.
    Shimizu J; Carrasco-Marin E; Kanagawa O; Unanue ER
    J Immunol; 1995 Oct; 155(8):4095-9. PubMed ID: 7561122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
    Peterson JD; Pike B; McDuffie M; Haskins K
    J Immunol; 1994 Sep; 153(6):2800-6. PubMed ID: 8077683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An association between type 1 diabetes mellitus and autoimmunity].
    Takeuchi K; Kuroda Y; Koike T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():407-12. PubMed ID: 12238081
    [No Abstract]   [Full Text] [Related]  

  • 37. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenesis of insulin-dependent (type I) diabetes mellitus].
    Weber B
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):355-63. PubMed ID: 2931586
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gene therapy for diabetes].
    Moritani M; Itakura M
    Nihon Rinsho; 1997 Nov; 55 Suppl():739-45. PubMed ID: 9434557
    [No Abstract]   [Full Text] [Related]  

  • 40. [Knockout mouse in the research of type 1 diabetes].
    Tamemoto H
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():52-7. PubMed ID: 12355801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.